Guest guest Posted May 3, 2004 Report Share Posted May 3, 2004 JustSayNo Wed, 28 Apr 2004 14:35:57 -0000 [sSRI-Research] AHRP speaks out against proposed NIH Misconduct Rules-Nature_New Scientist ALLIANCE FOR HUMAN RESEARCH PROTECTION (AHRP) Promoting openness and full disclosure http://www.ahrp.org FYI On April 19 NIH posted a request for comment about proposed rule change about research ethics in the Federal Register. NIH proposes to change the rules regarding whistleblowers " who historically have brought to light the majority of misconduct cases. " The New Scientist reports that " Representatives of professional research societies and US medical schools generally support the proposed changes. " This is not surprising, since they represent the institutions that have been found in violation of ethical research standards. An example of these societies' defense of a member institution that had been found to have conducted unethical research, is an Amicus Curiae brief filed by such professional associations on behalf of the Kennedy Krieger Institute (a subsidiary of Johns Hopkins University). Following the landmark decision by Maryland's highest court which issued a strong condemnation of Johns Hopkins research practices and the university's institutional research review boards that approved an experiment in which underprivileged babies were exposed to lead poison in partially abated homes. The experiment was a government funded study documenting the effects of partial lead abatement on these children's blood. The experiment was widely criticized by the public, but defended by the academic research community. The Maryland Court of Appeals decision (Higgins v KKI) is at: http://www.courts.state.md.us/opinions/coa/2001/128a00.pdf Amicus Briefs requesting the Court to reconsider were submitted by: The Association of American Medical Colleges, the Association of American Universities, Johns Hopkins University, the University of Maryland, and Medical System Corp. The Alliance for Human Research Protection was the only organization to file an Amicus brief in support of the Court decision--and we prevailed. See: http://www.ahrp.org/children/AmicusKKI.html The New Scientist and Nature (below) cite AHRP's position deploring these efforts to reduce the effectiveness of whistleblowers who are the best guides to evidence of institutional research violations. Contact: Vera Hassner Sharav Tel: 212-595-8974 e-mail: veracare April 26, 2004 NIH misconduct rules reviewed Professional societies support revisions to rules on whistleblowers and research misconduct | By Ted Agres The US Department of Health and Human Services, which includes the National Institutes of Health (NIH), has proposed changes to rules governing misconduct in federally sponsored research and the status of whistleblowers who allege scientific wrongdoing. The proposed rules, which update and standardize the definition of misconduct and the process for investigating and adjudicating complaints, would also expand the scope of plagiarism to cover individuals conducting peer review for funding or journal publication as well as scientists performing research. Representatives of professional research societies and US medical schools generally support the proposed changes, which replace regulations originally approved in 1989 and have been amended several times since. Among the changes are government-wide policies and procedures on research misconduct issued by the White House Office of Science and Technology Policy in 2000. The department is seeking public comment through June 15, 2004. The new rules are designed to " help ensure public confidence in the integrity of scientific data and the Public Health Service–supported research process, " according to Chris B. Pascal, director of the department's Office of Research Integrity. " We're pleased to see these, " said Howard Garrison, public affairs director for the Federation of American Societies for Experimental Biology. " We have to take a closer look at the provisions, but many of the changes are consistent with positions we have taken over the past several years, " he told The Scientist. Under the new rules, the scope of misconduct would be expanded to include research conducted under contract as well as that supported by grants. While continuing to define misconduct as " fabrication, falsification, or plagiarism, " the reach would be expanded to include scientists engaged in peer review for funding or publication in a scientific journal. " Since plagiarism in reviews has been known to occur, extending the reach of misconduct regulations seems perfectly appropriate, " said David Korn, senior vice president of Biomedical and Health Sciences Research at the Association of American Medical Colleges (AAMC). The proposed rules also redefine several key terms: " scientific misconduct " is changed to " research misconduct, " while " other practices, " a catchall phrase intended to be inclusive, would be dropped. " It was vague and confusing, " Garrison said, " and could lead to mistaken allegations of what is fair and not fair. " To be misconduct, the new rules would require fabrication, falsification, or plagiarism to be a " significant departure " from accepted practices, as opposed to the current standard of " serious deviation. " Once an allegation is made, the new rules would separate the inquiry and investigation phases from the adjudication and appeal phases. This " would level the playing field by providing the accused researchers with much needed notice of the required process to be used and protections offered in addressing the allegations, " the notice states. Whistleblowers, who historically have brought to light the majority of misconduct cases, would no longer be considered a " party " to the probe and guaranteed a role in the investigation. Instead, they would be " complainants " who do not participate beyond being a witness. " The institution may, but would no longer be required, to give the complainant an opportunity to comment on the inquiry and investigation reports, " the notice states. Institutions would still be obliged to pursue an allegation of misconduct and to protect the whistleblower from retaliation as long as the complaint was made in " good faith. " Not everyone is pleased with the proposed change in whistleblower status. " This is an effort to protect the institutions from serious investigations and accountability, " said Vera Hassner Sharav, president of the Alliance for Human Research Protection. " They are trying to eliminate the whistleblower's inclusion in the process. By doing that, they are insuring they will not obtain the relevant information, " she said. " If they don't know what to ask for, they are not going to get it. " But the AAMC's Korn said the whistleblower was like a witnesses in a criminal trial. " They present their knowledge and their facts, " he said. " They don't actually participate [in conducting] the trial. " Links for this article Department of Health and Human Services, " Public health service policies on research misconduct; proposed rule, " 42 CFR Parts 50 and 93, Federal Register, 69:20777-20803, April 16, 2004. Regulations.gov http://comments.regulations.gov/EXTERNAL/index.cfm?action==comme nt & docketId=-08647 http://www.regulations.gov/fredpdfs/04-08647.pdf L. DeFrancesco, " Researcher seeks whistleblower protection, " The Scientist, November 1, 2002. http://www.biomedcentral.com/news/20021101/04/ ©2004, The Scientist Inc. in association with BioMed Central http://www.nature.com/cgi-taf/DynaPage.taf? file==/nature/journal/v428/n6985/full/428786a_fs.html Nature 428, 786 (22 April 2004); doi:10.1038/428786a Health department lays down the law on scientific misconduct MEREDITH WADMAN [WASHINGTON] The US health department has issued comprehensive rules for handling scientific misconduct cases. And instead of kicking up a stink, most research organizations say that they find the regulations to their liking. On 19 April, the Department of Health and Human Services issued a 27- page notice in the Federal Register, which publishes rules for US federal organizations. The department has narrowed its current definition of research misconduct and set out procedures for universities and government officials investigating allegations of scientific wrong-doing by federally funded researchers. The regulations are probably the final chapter in a decade-long debate over what exactly constitutes scientific misconduct. And the department, which oversees most US biomedical research, has restricted the definition to " fabrication, falsification and plagiarism " — the offences that most researchers agree are egregious. The department has ditched the inclusion, in its current rules, of the ominous phrase " or other practices " , which scientists criticized as vague and overly broad. Last week's notice expands the definition of misconduct to say that it can occur during the review of grant proposals and journal articles. It also limits the role of whistle-blowers in investigations, stating that complainants may not participate except as witnesses. " What they have created is a consistent, clean definition, " says David Korn, senior vice-president for biomedical and health sciences research at the Association of American Medical Colleges. " Everybody understands what it means. " Not everyone shares Korn's cheerful perspective. " They are now saying a whistle-blower is merely someone who reports, and then stands aside, " complains Vera Sharav, president of the Alliance for Human Research Protection, a New York-based patient advocacy group. " That is outrageous. Who else knows how to guide the investigation to evidence of the violations? " Among other things, the revised policy requires complaints of misconduct to be filed within six years of the alleged event. The notice is open to public comment until 15 June, after which a final version will be published. FAIR USE NOTICE: This may contain copyrighted (© ) material the use of which has not always been specifically authorized by the copyright owner. Such material is made available for educational purposes, to advance understanding of human rights, democracy, scientific, moral, ethical, and social justice issues, etc. It is believed that this constitutes a 'fair use' of any such copyrighted material as provided for in Title 17 U.S.C. section 107 of the US Copyright Law. This material is distributed without profit. SSRI-Research/ Win a $20,000 Career Makeover at HotJobs Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.